Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 4/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | PDE5A | O76074 | 2/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23058684 | 0.97 | AHR (0.50) | AHRADORA3TNKSKMT2AMEN1 | |
| SCHEMBL23947895 | 0.95 | AHR (0.55) | AHRTNKSKMT2AMEN1ALDH1A1 | |
| SCHEMBL25894783 | 0.95 | AHR (0.55) | AHRTNKSKMT2AMEN1ALDH1A1 | |
| SCHEMBL21191833 | 0.92 | AHR (0.52) | AHRTNKSKMT2AMEN1ALDH1A1 | |
| SCHEMBL29918656 | 0.92 | AHR (0.44) | AHRADORA3TNKSKMT2AMEN1 | |
| SCHEMBL25019332 | 0.92 | ALDH1A1 (0.38) | AHRKMT2AMEN1ALDH1A1GAA | |
| SCHEMBL22329530 | 0.92 | ALDH1A1 (0.38) | AHRKMT2AMEN1ALDH1A1GAA | |
| SCHEMBL21191941 | 0.92 | AHR (0.55) | AHRKMT2ANPC1MAPK1HTT | |
| SCHEMBL22329684 | 0.92 | ALDH1A1 (0.38) | AHRKMT2AMEN1ALDH1A1GAA | |
| SCHEMBL23559216 | 0.91 | PLA2G2A (0.40) | AHRKMT2AMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873297-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11873297-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11807632-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11807632-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| EP-3770157-B1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEMICAL LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| US-20210323948-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
| US-20210139469-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| EP-3770157-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE USING SAME | LG CHEM, LTD. (KR) | 2021-01-27 | — | — | EP | disclosed |
| WO-2020085740-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE USING SAME | 주식회사 엘지화학 | 2020-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11807632-B2 | Heterocyclic compound and organic light emitting device comprising the same | ARNT, AHR, DRD1 | AHR 2/4885ADORA3 969/4885TNKS 3025/4885 |
| US-20210323948-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CCNL2, UBE2L3, OPRL1 | AHR 39/4885ADORA3 1058/4885TNKS 4000/4885 |
| US-20210139469-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | ARNT, AHR, DRD1 | AHR 2/4885ADORA3 969/4885TNKS 3025/4885 |
| US-11873297-B2 | Compound and organic light emitting device comprising the same | CCNL2, UBE2L3, ARL1 | AHR 44/4885ADORA3 1036/4885TNKS 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.